Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
MedinCell S.A. MEDCL.PA
$7.05
-$0.84 (-11.99%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
215058079.00000000
-
week52high
10.50
-
week52low
4.73
-
Revenue
4090000
-
P/E TTM
-7
-
Beta
1.01312900
-
EPS
-1.20000000
-
Last Dividend
0.00000000
-
Next Earnings Date
13 июн 2023 г. в 10:59
Описание компании
MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia; mdc-CWM, an intra-articular injection to treat pain and inflammation; and mdc-TJK, a subcutaneous injection in preclinical trials for use in the treatment of schizophrenia. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception; mdc-ANG for CNS related treatments; mdc-ELK for depression; and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. The company is based in Jacou, France.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии